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Introduction
E. coli strains can cause a lot of bacterial infections including 
gastroenteritis, urinary tract infections, neonatal meningitis, 
hemolytic uremic syndrome, mastitis and septicmia and for 
this reason they are considered as the most common pathogen 
of bacterial diseases worldwide. One of the serious concerns 
of clinical and veterinary medicine is antibiotic resistance 
observed from different bacteria [1]. Bacterial strains use 
several mechanisms to acquire resistance against common 
used antimicrobials, among them, production of extended 
spectrum β-lactamases (ESBLs) considered as the main 
mechanism [22]. ESBLs were first reported in 1983 and have 
been identified worldwide in a number of different organisms 
such as Klebsiella pneumonia, Escherichia coli, Proteus 
mirabilis, Enterobacter cloace, Morganella morgana, Serratia 
marcescence, Shigella dysenteriae, Pseudomonas aeroginosa 
and Salmonella species [2]. These enzymes cause resistance 
to extended spectrum cephalosporins and monobactams but 
do not affect carbapenems and cephamycins [2, 11]. There 
are different kind of ESBLs namely SHV, TEM, CTX-M, VEB 
and PER. The TEM1 enzyme was first found in E. coli isolates 
and now is considered as the most common β-lactamase 
produced by Enterobacteriaceae [22]. The CTX-M family is 
considered as a rapidly growing family of ESBLs that tends 
to hydrolyze cefotaxime rather than cephtazidime [19]. 
Enterobacteriaceae and Pseudomonas aeroginosa isolates 
produce VEB-1 ESBL and it was first reported from Thailand 
and the widespread presence of VEB-1 in mentioned 
bacteria suggests that this gene may exist in numerous gram 
negative species [8, 10]. The PER family, first reported in P. 
aeroginosa and manifests ESBL like activities. Although the 
predominance of ESBLs is not known, it is clearly increasing 
in different origins so, the aim of this study was to investigate 
the antibiotic susceptibility, prevalence of ESBL producing 
strains and occurrence of ESBL associated genes (TEM, 
CTX-M,VEB and PER) among E. coli isolates recovered from 
broiler fecal samples in northern Iran.  
SUMMARY
Extended-spectrum β-lactamase (ESBL) producing Escherichia coli have 
rapidly spread worldwide and cause serious threats for public health. 
The study was conducted to determine the antibiotic resistance and 
characterization of ESBL producing E. coli strains isolated from broilers 
in Northern Iran. Antibiotic susceptibility test was done for a total of 
100 isolates of E. coli, recovered from 240 broiler fecal samples at the 
slaughterhouse stage. ESBL production was screened using double-disc 
synergy test (DDST) and presence of four ESBL genes including blaPER, 
blaVEB, blaTEM and blaCTX-M  was tested using PCR. Among 100 strains isolated 
from broilers, 53% were identified as ESBL-producing E. coli. All (100%) 
ESBL positive isolates were typed according to the presence of one or two 
ESBL-associated genes. The most prevalent gene among ESBLs was CTX-M 
(60.3%) and the PER gene was not present among isolates. All isolates in 
this study were resistant to colistin and nalidixic acid but were 100% 
sensitive to cefalexin and furazolidone. The results demonstrated the high 
prevalence of antibiotic resistant and ESBL producing E. coli among broilers 
which representing the risk of increasing these strains in human infections 
associated with food animals.
Keywords: E. coli, Antibiotic susceptibility, ESBL genes, 
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RÉSUMÉ
Sensibilité aux antibiotiques et prévalence élevée d’ Escherichia coli 
porteurs de béta lactamases à large spectre chez les poulets en Iran. 
Des Escherichia coli porteurs de béta-lactamases à large spectre (Extended-
spectrum β-lactamase, ESBL) se propagent rapidement dans le monde 
entier et causent de graves menaces pour la santé publique. Cette étude a 
été menée afin de déterminer la résistance aux antibiotiques et caractériser 
la production d’ESBL par des E. coli isolés de poulets de chair dans le nord 
de l’Iran. Un test de sensibilité aux antibiotiques a été fait sur un total de 
100 isolats obtenus à partir de 240 échantillons fécaux de poulets de chair à 
l’abattoir. La production d’ESBL a été criblée en utilisant un test de synergie 
à deux disques et en recherchant par PCR la présence de quatre gènes de 
résistance, dont blaPER, blaVEB, blaTEM et blaCTX-M. Parmi les 100 souches isolées 
de poulets de chair, 53% ont été identifiés comme E. coli producteurs d’ESBL. 
Tous les isolats producteurs d’ESBL ont été typés pour la présence d’un ou 
deux gènes. Le gène le plus répandu était CTX-M (60,3%) alors que le gène 
PER n’était pas présent parmi les isolats. Tous les isolats de cette étude étaient 
résistants à la colistine et l’acide nalidixique, mais était 100% sensibles à la 
céfalexine et furazolidone. Ces résultats ont démontré la haute prévalence 
des souches résistantes aux antibiotiques E. coli producteur  d’ESBL chez les 
poulets de chair en Iran.
Mots-clés : E. coli, sensibilité, antibiotiques, résistance, 
béta-lactamase, PCR, poulet.
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Materials and methods
SAMPLING PROTOCOL AND BACTERIAL STRAINS 
During January to March 2014, a total of 240 fecal 
samples were collected from cloaca of healthy slaughtering 
broilers in three slaughterhouses in ten visits. Fecal samples 
were collected in TSB broth tubes using sterile swabs and 
taken to the microbiological laboratory, School of Veterinary 
Medicine, Amol University of Special Modern Technologies, 
in less than 6 hrs. Fecal swabs were cultured on MacConkey 
and EMB agar (Himedia, India) and incubated at 37°C for 
18-24 h. Indole, methyl red, Voges-Proskauer reaction and 
Simons citrate tests were performed with the colonies that 
showed growth features of  E. coli.  Identified isolates were 
subjected to the antimicrobial and molecular procedures.
ANTIMICROBIAL DRUG SUSCEPTIBILITY TESTING AND 
ESBL DETECTION
Antimicrobial drug susceptibility was assessed by disc-
diffusion method on Mueller-Hinton (MH) agar plates 
(Merck, Germany), according to the antibiogram standard 
methods [5]. Tested antimicrobial agents were as followed: 
Colistin (10µg), ciprofloxacin (5µg), nalidixic acid (30μg), 
ampicillin (10µg), sulfamethoxazole-Trimethoprim (30μg), 
gentamicin (10µg), cephalotin (30 µg), cefexime (30 µg), 
cefalexin (30µg), cefotaxime (30µg), Furazolidone (30µg), 
Florfenicol (30µg), Erythromycin (15µg) and Nitrofurantoin 
(50µg). Quality control was carried out using the reference 
strain E. coli ATCC 25922. To screen ESBL production a 
double-disc synergy test (DDST) was used as a standard 
disc-diffusion assay on MH agar. For this purpose, Discs 
containing ceftazidime (30 mg) and cefotaxime (30 mg) were 
placed at a distance of 30 mm (centre to centre) around a 
disc containing cefotaxime/clavulanic acid (20/10 mg) and 
ceftazidime/clavulanic acid (20/10 mg). Isolates that showed 
difference in the inhibition zone more than five mm, were 
considered as ESBL producing strains [5].  
DNA PREPARATION
A loopful colony of each isolate on agar plate was picked 
and then suspended in 200 µl of distilled deionized water. 
After vortexing, the suspension was boiled for 5 min, and 50 
µl of the supernatant was collected after spinning for 10 min 
at 14,000 rpm in a micro centrifuge. The DNA concentration 
of boiled extracts was determined with spectrophotometer 
[16].
PCR ASSAY
In the present study, PCR amplifications were performed 
in a final volume of 25 µL in PCR tubes. The PCR reaction 
mixtures consisted of 2 µL of the DNA template, 2.5 µL10x 
PCR buffer (75 mMTris-HCl, pH 9.0, 2 mM MgCl2, 50 
mMKCl,20 mM (NH4)2SO4), (CinnaGen, Iran), 1 µL 
dNTPs (50 µM), (CinnaGen, Iran), 1 µL (1U Ampli Taq 
DNA polymerase), (CinnaGen, Iran), 1 µL (25 pmol) from 
the forward and reverse primers (CinnaGen, Iran), of both 
primer pairs (Table I) and the volume of the reaction mixture 
was completed to 25 µL using distilled deionized water. The 
thermal cycler (MJ mini, BioRad, USA) was adjusted under 
the following specifications: Initial denaturation at 94°C for 
Primer Sequence (5` to 3`) Target gene Annealing temperature
Product size 
(bp) Reference
CTX-1-un-F
CTX-1-un-R
CATGTGCAGYACCAGTAA
CCGCRATATCRTTGGTGGTG blaCTX-M-1 cluster 42ºC 544 [21]
PERF
PERR
ATGAATGTCATTATAAAAGC
AATTTGGGCTTAGGGCAGAA blaPER 47ºC 925 [10]
VEBF
VEBR
CGACTTCCATTTCCCGATGC
GGACTCTGCAACAAATACGC blaVEB 51ºC 643 [17]
OT3
OT4
ATGAGTATTCAACATTTCCG
TTACCAATGCTTAATCAGTGA blaTEM 46ºC 858 [7]
Table I: Nucleotide sequences used as primers in the PCR reactions.
Strains 
(No)
Antibiotic resistant pattern (%)
CL CP NA AM SXT GM CF CFM CN CTX FR FF E FM
Total 
(100)
ESBLs 
(53)
100
(100)
53
(100)
39
(39)
30
(56.6)
100
(100)
53
(100)
90
(90)
53
(100)
86
(86)
42
(79.2)
36
(36)
19
(35.8)
100
(100)
53
(100)
0
(0)
0
(0)
23
(23)
20
(37.7)
0
(0)
0
(0)
0
(0)
0
(0)
72
(72)
33
(62.2)
87
(87)
50
(94.3)
20
(20)
28
(52.8)
CL, Colistin; CP, Ciprofloxacin; NA, Nalidixic acid; AM, Ampicillin; SXT, Sulfamethoxazole-trimethoprime; GM, Gentamycin; CF, Cephalotin; CFM, Cefexime; 
CN, Cefalexin; CTX, Cefotaxime; FR, Furazolidone; FF, Florfenicole; E, Erythromycin; FM, Nitrofurantoin.
Table II: Antimicrobial resistance of E. coli strains isolated from broiler fecal samples.
Revue  Méd. Vét., 2016, 167, 5-6, 133-137
ESBL E. COLI IN BROILERS 135
5 min, followed by 35 cycles of denaturation at 94°C for 1 
min, annealing as shown in Table I for 1 min and extension at 
72°C for 1 min. Final extension was carried out at 72°C for 7 
min and the PCR products were stored in the thermal cycler 
at 4°C until they were collected. Then amplified products 
were separated by electrophoresis in 1.2% agarose gel stained 
with ethidium bromide. Visualization was undertaken using 
a UV transilluminator and the 100 bp, DNA ladder was used 
as molecular size marker.
Results
In this study a total of 100 E. coli isolates were recovered 
and distinguished from 240 randomly collected broiler fecal 
samples. The isolated organisms were identified for their 
antibiotic resistance and presence of PER, VEB, CTX-M and 
TEM ESBL-associated genes. Antimicrobial resistance pattern 
of isolated organisms are shown in table II. All 100 isolates 
in this study were resistant to colistin and nalidixic acid but 
were 100% sensitive to cefalexin and furazolidone. Among 
the isolates, 90, 87, 86 and 72% showed relatively high level 
of resistance to ampicillin, erythromycin, sulfamethaxazole 
and florfenicole respectively. Fifty three percent of all E. coli 
isolates were ESBL producing. PCR analysis was performed 
and agarose gel electrophoresis of the mentioned genes 
obtained from ESBL producing E. coli are shown in Figures 
1, 2 and 3. The rate of the distribution of ESBL genes is 
presented in table III. The occurrence of the CTX-M, TEM 
and VEB genes among ESBL isolates were, 60.3% (32/53), 
37.7% (20/53) and 13.2% (7/53) respectively. The PER gene 
was not present. Among ESBL strains 6 (11.2%) showed 
multiple presence of ESBL associated genes (Table III).
Discussion
It has been proved that among gram negative pathogens 
such as Enterobacteriaceae family, resistance to an extended 
spectrum β-lactamase is widely associated with ESBLs. For 
this reason accurate identification and isolation of such 
microorganisms is a great challenge for clinical associated 
laboratories that can use both phenotypic and genotypic tests 
for detection of genes related with β-lactamase production 
[4, 13]. ESBL producing E. coli has been widely isolated 
from different animals. The first CTX-M producing E. coli 
in healthy chickens and cattle was reported in 2001 in Spain 
and Japan respectively [18, 23]. Afterward this organism has 
been isolated from wide range of animals and their related 
Number of 
isolates ESBL producing (%) Positives for ESBL genes (%)
PER VEB CTX-M CTX-M+VEB
CTX-
M+TEM TEM
100 53 (43) 0 (0) 4 (7.5) 26 (49) 3 (5.6) 3 (5.6) 17 (32)
Table III: Occurrence of ESBL producing E. coli and ESBL-associated genes among broiler fecal isolates.
Figure 1:Agarose gel electrophoresis of CTX-M PCR products.
Lanes 1-2: Negative samples; Lanes 3-6: Positive samples;
Lane 7: negative control; Lane M: the 100 bp DNA marker.
Figure 2:Agarose gel electrophoresis of blaTEM PCR products.
Lanes 1-2: Positive samples; Lanes 3-4: Negative samples;
Lane 5-6: Positive and negative controls; Lane M: the 100 bp DNA marker.
Figure 3:Agarose gel electrophoresis of VEB genePCR products.
Lanes 1-4 Positive samples;Lane M: the 100 bp DNA marker.
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products including chicken meat samples in Tunisia, cattle 
and poultry samples in France, broiler chickens in Japan 
and Belgium [12, 15, 24, 25]. ESBL E. coli has become 
widespread in humans since their first appearance in 1989 
and it is important to take attention to possibility relation 
of this bacterium between animals and human [18]. Refer 
to published reports, the prevalence of ESBLs producing 
E. coli is in a range of 5% in Japan to 50% in other Asian 
countries and in Europe, the prevalence varies from 3% 
in Sweden to 34% in Portugal [3, 4, 26]. There are some 
reports on prevalence of E. coli carrying ESBLs from pets 
and wild animals but to our knowledge, there are limited 
investigations on prevalence of ESBLs producing E. coli 
from chickens and poultry fecal samples. CORTES et al. [6] 
after isolation and characterization of potentially pathogenic 
antimicrobial resistant E. coli strains from chicken and pig 
farms in Spain reported that isolates from poultry and pig 
farms differ with respect to ESBL associated genes, serotypes 
and virulence genes and in their study the isolates from 
poultry are potentially more pathogenic for humans than 
those from pigs. In another study GIRLICH et al. [9] after 
detection of genes encoding extended spectrum β-lactamase 
CTX-M-1 in 12 E. coli isolates, reported a widespread 
diffusion of CTX-M-1 in E. coli in food producing poultry 
in France. RANDALL et al. [18] reported that the prevalence 
of E. coli carrying ESBLs from broiler chickens and turkeys 
in Great Britain between 2006 and 2009 were 54.5% in the 
broiler abattoirs and 3.6% in individual broiler fecal samples 
and they concluded that poultry derived CTX-M E. coli in 
Great Britain are different from major CTX-M sequence types 
causing disease in humans. To the best of our knowledge, 
epidemiologic data and characterization of ESBL producing 
E. coli in Iran are not documented completely. According 
to results of present study, high occurrence of ESBL E. coli 
strains was obtained (53%) relatively. Although this result 
is lower than those of RANDALL et al. [18] those ESBLs 
producing E. coli was 54.5% of the broiler samples. This study 
reports a high dissemination of CTX-M gene (60.3%) in 
ESBL producing E. coli strains. There are several studies that 
reports CTX-M as the main gene responsible for antibiotic 
resistance of ESBLs E. coli [6, 18]. The VEB β-lactamase gene 
was detected in 7.5% (4/53) of ESBL positive E. coli strains. 
Interestingly, the PER gene was not detected among 100 E. 
coli isolates. As can be seen in Table III the presence of the 
TEM gene was more frequent in comparison with PER and 
VEB genes and although we did not investigate the presence 
of other ESBL-associated genes like SHV which were 
predominant in past decades, it seems that in this sampling 
area the CTX-M and TEM genes manifested essential role in 
creating antibiotic resistance of ESBLs E. coli. Three (5.6%) 
of total 53 ESBL positive samples had both CTX-M and 
VEB and three (5.6%), had CTX-M and TEM together and 
it seems that they formed relatively high portion of isolated 
E. coli strains. The epidemiological distribution of ESBLs 
associated genes is different. It has been documented that 
PER-1 are detected more in isolates in Turkey, France and 
Italy [20]. VEB-1 and VEB-2 are identified in strains from 
Southeast Asia and CTX-M gene, the dominant non-TEM 
ESBL among Enterobacteriaceae, have been detected in wide 
epidemiological area and have disseminated in all countries 
as a result of epidemic plasmids and/or particular epidemic 
strains [14, 20]. Results of antimicrobial susceptibility testing 
showed that isolates from broiler samples manifested high 
resistance to colistin, nalidixic acid and cephalotin with 
100% resistance. As presented in Table II, tested isolates 
were completely resistant to first generation cephalosporin 
(cephalotin) and interestingly showed full susceptibility to 
third generation cephalosporins (cephotaxime and cefexime). 
Resistance to these antibiotics can be related to other ESBL-
associated genes. All cefalexin resistant isolates were ESBL 
and there were no significant differences between ESBLs 
and non-ESBL isolates in antibiotic susceptibility testing. 
These results revealed that replacing of first generation 
cephalosporins with third generation ones can help to reduce 
the ESBLs producing E. coli infections in this region of Iran. 
In conclusion, we report the relatively high prevalence and 
molecular properties of ESBL genes and the epidemiological 
characteristics of ESBLs producing E. coli in Iran. Data would 
suggest that blaCTX-M to be the most prevalent ESBLs gene 
and antibiotic susceptibility testing showed that isolates had 
high rate of resistance against the colistin, nalidixic acid and 
cephalotin. 
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